Stress Biology in Cancer: Neuroendocrine–Immune Mechanisms Linking Tumor Progression to Translational Interventions
Cancer Communications · 2026
DOI: 10.34133/cancomm.0053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Communications, 2026. Verfasst von Chi Ma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, P. R. China. Hauptthemen laut MEDLINE: Neoplasms, Stress, Physiological, Neurosecretory Systems. Die Arbeit nennt 390 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic stress-responsive signaling has emerged as a modifiable dimension of cancer biology by linking systemic neuroendocrine activation to tumor-cell adaptation, metabolic rewiring, immune suppression, tumor microenvironment remodeling, metastatic dissemination, and therapeutic resistance. Persistent activation of the sympathetic nervous system (SNS) and the hypothalamic pituitary adrenal (HPA) axis elevates catecholamines and glucocorticoids, which act through adrenergic receptors and the glucocorticoid receptor (GR) in tumor, stromal, vascular, and immune compartments. These canonical pathways regulate cyclic adenosine monophosphate (cAMP)–protein kinase A (PKA) signaling, GR-dependent transcription, angiogenic and inflammatory programs, extracellular matrix remodeling, myeloid polarization, T cell dysfunction, and resistance to cytotoxic and immune-based therapies. Beyond this classical SNS/HPA framework, emerging evidence indicates that cancer cells also engage noncanonical stress-adaptive hubs, including ion-channel signaling, redox-dependent mitochondrial responses, integrated stress-response pathways, prolactin/prolactin receptor signaling, and neurotrophin-mediated tumor–stroma–nerve crosstalk. These mechanisms are particularly relevant in highly plastic and immunogenic tumors such as melanoma, where stress adaptation intersects with immune visibility, metabolic flexibility, and therapy response. In this review, we synthesized how chronic stress signaling operates across systemic, tumor-intrinsic, immune, stromal, vascular, metabolic, and neural niches. We further mapped cancer-specific mechanisms across major malignancies and evaluated translational strategies, including β- and α-adrenergic blockade, GR modulation, stress-reducing behavioral interventions, and combination approaches with immunotherapy or standard anticancer regimens. Moreover, we discussed clinical challenges, including heterogeneity in stress exposure, context-dependent receptor activity, sex-specific stress biology, evidence maturity, and the need for biomarker-guided patient stratification. This integrated framework supports the development of mechanism-based stress-targeted adjunctive therapies in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Clinical Laboratory, Qilu Hospital of Shandong University, Jinan, Shandong, P. R. China.
- Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, P. R. China.
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
- Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Riga, Latvia.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, C., Ma, Y., Xing, X., Sun, C., Guan, L., Schiöth, H. B., & Liu, W. (2026). Stress Biology in Cancer: Neuroendocrine–Immune Mechanisms Linking Tumor Progression to Translational Interventions. Cancer Communications. https://doi.org/10.34133/cancomm.0053
Vancouver
Ma C, Ma Y, Xing X, Sun C, Guan L, Schiöth HB, et al. Stress Biology in Cancer: Neuroendocrine–Immune Mechanisms Linking Tumor Progression to Translational Interventions. Cancer Communications. 2026. doi:10.34133/cancomm.0053
BibTeX
@article{Ma2026,
author = {Ma, Chi and Ma, Yukang and Xing, Xiangling and Sun, Chengxi and Guan, Li and Schiöth, Helgi B and Liu, Wancheng},
title = {Stress Biology in Cancer: Neuroendocrine–Immune Mechanisms Linking Tumor Progression to Translational Interventions},
journal = {Cancer Communications},
year = {2026},
doi = {10.34133/cancomm.0053}
}
EUVIMED